Search PDMR transactions

Notifier
Name of person with notification obligation
Stefan Nilsson
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Stefan Nilsson
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Lipigon Pharmaceuticals AB
Issuer´s LEI code
549300XPO40YR12SLY87
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Lipigon Pharmaceuticals AB SE0015382072 Exercise increase 52,500 Quantity 0.20 SEK 03/06/2024 Outside a trading venue
Option Lipigon Pharmaceuticals AB TO3 SE0019914102 Exercise decrease 52,500 Quantity 0.20 SEK 03/06/2024 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Lipigon Pharmaceuticals AB SE0015382072 Exercise increase 03/06/2024 Outside a trading venue 52,500 (Quantity) 0.20 SEK
Lipigon Pharmaceuticals AB TO3 SE0019914102 Exercise decrease 03/06/2024 Outside a trading venue 52,500 (Quantity) 0.20 SEK
<< Back